Home › Funds › NAN FUNG TRINITY (HK) Ltd › CLYM
NAN FUNG TRINITY (HK) Ltd position in CLYM
CLIMB BIO INC · Health Care
NAN FUNG TRINITY (HK) Ltd reported holding 360,654 shares of CLYM (CLIMB BIO INC) in its Q3 2026 13F filing — a position valued at US$4.1M, representing 0.40% of its reported portfolio and ranking #49 among its reported holdings. NAN FUNG TRINITY (HK) Ltd has disclosed CLYM holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How NAN FUNG TRINITY (HK) Ltd's CLYM position evolved
NAN FUNG TRINITY (HK) Ltd first disclosed a stake in CLYM in Q2 2025 at 463,654 shares (US$575K). The position peaked in Q2 2026 at 360,654 shares, worth US$4.7M. Across 6 filings, NAN FUNG TRINITY (HK) Ltd increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 360,654 shares valued at US$4.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 463.65K | $574.93K | New |
| Q3 2025 | 463.65K | $931.95K | Hold |
| Q4 2025 | 463.65K | $1.85M | Hold |
| Q1 2026 | 420.52K | $2.88M | Reduce |
| Q2 2026 | 360.65K | $4.70M | Reduce |
| Q3 2026 | 360.65K | $4.14M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CLYM and 13F data
CLYM (CLIMB BIO INC) is a Health Care company. 73 other funds we track also report a position in CLYM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$147.4M), BRAIDWELL LP (US$36.5M), Cormorant Asset Management, LP (US$27.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CLYM
- RA CAPITAL MANAGEMENT, L.P. 11.30M sh · $147.36M · Q2 2026
- BRAIDWELL LP 2.80M sh · $36.48M · Q2 2026
- Cormorant Asset Management, LP 2.11M sh · $27.46M · Q2 2026
- Redmile Group, LLC 1.23M sh · $15.99M · Q2 2026
- GREAT POINT PARTNERS LLC 1.00M sh · $13.04M · Q2 2026
- Affinity Asset Advisors, LLC 972.00K sh · $12.67M · Q2 2026
- ADAR1 Capital Management, LLC 822.65K sh · $10.73M · Q2 2026
- STEMPOINT CAPITAL LP 742.75K sh · $9.69M · Q2 2026
- Parkman Healthcare Partners LLC 563.48K sh · $7.35M · Q2 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 521.08K sh · $6.79M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 483.75K sh · $6.31M · Q2 2026
- Ally Bridge Group (NY) LLC 249.17K sh · $3.25M · Q2 2026
More on NAN FUNG TRINITY (HK) Ltd
FAQ
How long has NAN FUNG TRINITY (HK) Ltd held CLYM?
NAN FUNG TRINITY (HK) Ltd has disclosed CLYM holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is NAN FUNG TRINITY (HK) Ltd's current position in CLYM?
As of Q3 2026, NAN FUNG TRINITY (HK) Ltd holds 360.65K shares of CLYM (CLIMB BIO INC), valued at $4.14M, representing 0.40% of its reported portfolio and ranking #49.
Has NAN FUNG TRINITY (HK) Ltd been buying or selling CLYM?
In the latest 13F filing (Q3 2026), NAN FUNG TRINITY (HK) Ltd held unchanged its position in CLYM. The position peaked in Q2 2026 at 360.65K shares.
Which other funds hold CLYM?
Other major institutional holders of CLYM include RA CAPITAL MANAGEMENT, L.P., BRAIDWELL LP, Cormorant Asset Management, LP, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.